What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia (Part 1 of a 4-Part Series) - Slide Archive | Research To Practice

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia (Part 1 of a 4-Part Series) - Slide Archive

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia (Part 1 of a 4-Part Series)

Please note that slides and other materials provided are for review only and not to be repurposed or published.

A 4-Part Friday Satellite Symposia Series Preceding the 63^rd ASH Annual Meeting and Exposition

Friday, December 10, 2021

MODULE 1: Front-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) — Anthony R Mato, MD, MSCE

MODULE 2: Novel Strategies Combining Bruton Tyrosine Kinase (BTK) and Bcl-2 Inhibitors for CLL — John N Allan, MD

MODULE 3: Optimal Management of Adverse Events with BTK and Bcl-2 Inhibitors; Considerations for Special Patient Populations — Nitin Jain, MD

MODULE 4: Selection and Sequencing of Available Therapies for R/R Disease — John M Pagel, MD, PhD

MODULE 5: Promising Investigational Agents and Strategies — Jennifer Woyach, MD